Related references
Note: Only part of the references are listed.WHO Launches Global Push to Eliminate Cervical Cancer
Bridget M. Kuehn
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
WHO launches strategy to accelerate elimination of cervical cancer
Manjulika Das
LANCET ONCOLOGY (2021)
2020 list of human papillomavirus assays suitable for primary cervical cancer screening
Marc Arbyn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Trends in cervical cancer incidence in sub-Saharan Africa
Elima Jedy-Agba et al.
BRITISH JOURNAL OF CANCER (2020)
Commercially available molecular tests for human papillomaviruses: a global overview
M. Poljak et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
HPV-based cervical cancer screening, including self-sampling, versus screening with cytology in Argentina
Marc Arbyn et al.
LANCET GLOBAL HEALTH (2019)
Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy Demonstration Project in Argentina: a population-based, before-and-after retrospective cohort study
Silvina Arrossi et al.
LANCET GLOBAL HEALTH (2019)
HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology: Data From the Baseline Phase of the Onclarity Trial
Mark H. Stoler et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2019)
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology
Mark H. Stoler et al.
GYNECOLOGIC ONCOLOGY (2019)
The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women
X. Zhao et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
A cohort study of cervical screening using partial HPV typing and cytology triage
Mark Schiffman et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test
Mark Schiffman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Five-Year Cervical (Pre)Cancer Risk of Women Screened by HPV and Cytology Testing
Margot H. Uijterwaal et al.
CANCER PREVENTION RESEARCH (2015)
Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance
Warner K. Huh et al.
GYNECOLOGIC ONCOLOGY (2015)
Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large US screening population: Data from the ATHENA trial
Joseph Monsonego et al.
GYNECOLOGIC ONCOLOGY (2015)
Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology
Louise T. Thomsen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A Study of Genotyping for Management of Human Papillomavirus-Positive, Cytology-Negative Cervical Screening Results
M. Schiffman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States
Cosette M. Wheeler et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Five-Year Risks of CIN 3+and Cervical Cancer Among Women Who Test Pap-Negative But Are HPV-Positive
Hormuzd A. Katki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
L. Stewart Massad et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
Benchmarking CIN 3+Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines
Hormuzd A. Katki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
Debbie Saslow et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV plus Cytology-Negative Results
Thomas C. Wright et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18
Wen Chen et al.
CANCER CAUSES & CONTROL (2009)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
